ENHANCEMENT OF MURINE LYMPHOMA CELL LYSABILITY BY CTL AND BY LAK CELLS, AFTER TREATMENTS WITH MITOMYCIN-C AND WITH ADRIAMYCIN

被引：19

作者：

LEROUX, JY ^{[1
]}

MERCIER, G ^{[1
]}

OTH, D ^{[1
]}

机构：

[1] UNIV QUEBEC,INST ARMAND FRAPPIER,CTR RECH IMMUNOL,CP 100,LAVAL H7N 4Z3,QUEBEC,CANADA

来源：

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1986年 / 8卷 / 03期

关键词：

D O I：

10.1016/0192-0561(86)90119-0

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：369 / 375

页数：7

相关论文

共 28 条

[1] DIFFERENTIAL VARIATIONS OF SENSITIVITIES OF TNP-MODIFIED LYMPHOMA-CELLS TO LYSIS BY CYTO-TOXIC LYMPHOCYTES AND BY ANTIBODIES
BISCHOFF, P
MAUGRAS, M
OTH, D
[J]. IMMUNOLOGY LETTERS, 1982, 4 (02) : 107 - 111
[2] CHEEVER MA, 1981, J IMMUNOL, V126, P1318
[3] DALE MM, 1984, INT J IMMUNOPHARMACO, V6, P279
[4] DEEM RL, 1984, J IMMUNOL, V133, P72
[5] DONOHUE JH, 1984, J IMMUNOL, V132, P2123
[6] DIFFERENTIAL INTERACTION OF DAUNOMYCIN, ADRIAMYCIN AND THEIR DERIVATIVES WITH HUMAN ERYTHROCYTES AND PHOSPHOLIPID BILAYERS
GOLDMAN, R
FACCHINETTI, T
BACH, D
RAZ, A
SHINITZKY, M
[J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1978, 512 (02) : 254 - 269
[7] KESSEL D, 1979, MOL PHARMACOL, V16, P306
[8] METABOLIC-INHIBITORS RENDER RESISTANT TARGET-CELLS SENSITIVE TO NATURAL-KILLER CELL-MEDIATED LYSIS
KUNKEL, LA
WELSH, RM
[J]. INTERNATIONAL JOURNAL OF CANCER, 1981, 27 (01) : 73 - 79
[9] AUGMENTATION OF INVITRO CYTO-TOXICITY AND INVIVO TUMOR-INHIBITION BY COMBINED USE OF LYMPHOTOXIN-CONTAINING SUPERNATANTS AND ANTI-TUMOR DRUGS
MATSUNAGA, K
MASHIBA, H
[J]. CANCER LETTERS, 1983, 20 (01) : 21 - 28
[10] MAZUMDER A, 1983, CANCER RES, V43, P5729